News
Clinical Trials Arena on MSN16h
Lipella enrols all subjects in Phase IIa trial targeting oral lichen planusThe trial is designed to assess LP-310’s tolerability, preliminary efficacy, and safety in adults with symptomatic OLP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback